Dr. Farr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-5505Fax+1 214-645-4915
Summary
- Maryjane Farr joined UT Southwestern Medical Center in September 2021 as Professor of Medicine and Section Chief of Heart Failure, VAD and Transplant. Previously she was the Irene and Sidney B. Silverman Associate Professor of Medicine and Medical Director of the Adult Heart Transplant Program at Columbia University Irving Medical Center.
Dr. Farr is a graduate of Barnard College, Columbia University (BA’89), Columbia College of Physicians & Surgeons, AOA (’98) and the Columbia Mailman School of Public Health (MSc’12). Dr. Farr was the Director of Clinical Trials in Heart Failure and Transplant at Columbia from 2007-12, received an NIH training grant for her master’s degree (2010-12), and was awarded the Shorin-Silverstein Research in Transplantation Award (at Columbia) for 2012-14.
Dr. Farr directed the Adult Heart Transplant Program at Columbia for 6 years, and she has authored more than 100 peer-reviewed manuscripts in the field of heart failure, VAD or transplant. She has participated in scholarly work and education with the ACC, AHA, HFSA, ISHLT and AST. She has been an active member and leader in UNOS/OPTN serving three years on the Thoracic Committee including Heart Subcommittee Chair, two years on the Membership and Professional Standards Committee, two years as region 9 Associate Councilor and was recently appointed to the UNOS/OPTN Board of Directors.
She is an Associate Editor of Transplantation and Content Editor for Circulation.
Her key areas of interest are in organ allocation, primary graft failure, minimization of immunosuppression and overall long-term survival of heart transplant recipients.
Education & Training
- Columbia University Mailman School of Public HealthMSc, Patient Oriented Research, 2011
- Barnard CollegeBA, Philosophy, cum laude, 1989
- New York Presbyterian Hospital (Columbia Campus)Post-Doctoral Fellowship, Cardiovascular Disease, 2004 - 2005
- New York Presbyterian Hospital (Columbia Campus)Post-Doctoral Fellowship, Advanced Heart Failure and Transplant Cardiology, 2003 - 2004
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Cardiovascular Disease, 2001 - 2004
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Certifications & Licensure
- NY State Medical License 2000 - 2025
- TX State Medical License 2021 - 2025
- CT State Medical License 2018 - 2021
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow of the American Heart Association AHA, 2023
- Fellow of the Heart Failure Society of America HFSA, 2023
- Fellow of the American Society of Transplantation AST, 2021
- Join now to see all
Clinical Trials
- A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure Start of enrollment: 2012 Jul 01
- Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. Start of enrollment: 2012 Jul 01
- An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) Start of enrollment: 2013 Feb 20
- Join now to see all
Publications & Presentations
PubMed
- Influence of Age on the Impact of a Natriuretic Peptide-Guided Treatment Strategy in Patients With Heart Failure.Caleb J Hood, Anand Gupta, Nicholas S Hendren, Maryjane A Farr, Mark H Drazner
The American Journal of Cardiology. 2025-01-01 - What Drives Transplant Outcomes Following Donation After Circulatory Death: Procurement Method or Provider Volume?Maryjane Farr, Sean Pinney
JACC. Heart Failure. 2024-12-01 - Revisiting Biomarkers of Cardiac Allograft Vasculopathy: Addressing the Achilles Heel of Heart Transplantation.Patrick E O'Hara, Ananya Gorrai, Maryjane Farr, Matthias Peltz, Hadi Beaini
Current Heart Failure Reports. 2024-12-01
Journal Articles
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicLauren Sinnenberg, Nosheen Reza, Michelle M Kittleson, Veli K Topkara, Maryjane A Farr, JAMA Cardiology
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
- VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
Authored Content
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Join now to see all
Committees
- Region 9 Representative, Members and Professional Standards Committee, UNOS 2019 - Present
- Region 9 Representative, UNOS Thoracic Committee 2014 - Present
- Board Member, UNOS/OPTN Board of Directors 2021 - 2023
Professional Memberships
- Member
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: